This month we are joined by Dr Tom Newsom-Davis from Chelsea and Westminster Hospital, London, who discusses The Role of Adjuvant Targeted Therapies and Immunotherapy for Completely Resected Early-Stage NSCLC. It is co-chaired by Prof Raffaele Califano, from The Christie, Manchester. Our two speakers engage in a disucssion to close the episode.
Version: 20240731
Comments (0)
To leave or reply to comments, please download free Podbean or
No Comments
To leave or reply to comments,
please download free Podbean App.